


The SigDyn team receives Obtention two major grants
The SigDyn team receives Obtention two major grants The SigDYN team has obtained two major grants to study : Functional exploration of early pre metastatic niche in the liver for various cancers PI3K deregulation & Early detection and treatment of pancreatic...
Dr. Marc Poirot new member of the Editorial Board of the JBC
Dr. Marc Poirot new member of the Editorial Board of the JBC Dr. Marc Poirot, head of the INOV team “Cholesterol Metabolism and Therapeutic Innovations” at the CRCT, will join the Editorial Board of the Journal of Biological Chemistry (JBC) in 2025. The...
The DIAD team receives funding from the Ligue Nationale contre le Cancer
Funding obtained (400 000 euros from Ligue Nationale contre le Cancer – Clinical Research 2024) for a research project on the influence of morphological characteristics on the pharmacokinetics and toxicity of trastuzumab deruxtecan in patients with...
Prize for the best communication at the French Association for Pancreatic Cancer Research (AFRCP) day.
Prize for the best communication at the French Association for Pancreatic Cancer Research (AFRCP) day. The IFNy response in tumor/stroma interactions of a novel subtype of Pancreatic Adenocarcinoma: antigenic peptide translation and Antigen-presenting CAF Award...